Skip to main content

Homology Medicine: Overview of Clinical Stage Pipeline

 Clinical Stage Therapeutic Area

Adult Phenylketonuria (PKU)

Metachromatic Leukodystrophy (MLD)

Adult Phenylketonuria (PKU)

Phenylketonuria is a disorder of phenylalanine metabolism. In the patients with uncontrolled PKU, the blood Phenylalanine (Phe) level may rise above 1200 µM concentration. The clinical manifestations include growth failure, microcephaly, seizures, and intellectual impairment caused by the accumulation of toxic by-products of Phe.
Gene Defect: Mutation in the PAH gene that encodes for enzyme phenylalanine hydroxylase that converts phenylalanine to tyrosine. PKU is inherited in an autosomal recessive manner
Treatment Approach: HMI-102 is an investigational gene therapy designed to deliver the functional copy of the PAH gene to the adult patients using the AAVHSC vector. Specifically, administration of the AAVHSC-based gene editing constructs may result in the integration of the human PAH gene in human hepatocytes
Clinical Stage: Phase 1/2

Metachromatic Leukodystrophy (MLD)

In MLD, defective lysosomal degradative enzyme results in the cellular components accumulate and destroy myelin-producing cells in the peripheral and central nervous system leading to progressive and serious neurological deterioration. 
Gene Defect: MLD is a rare lysosomal storage disorder caused by a mutation in the ARSA gene. ARSA is responsible for the synthesis of the arylsulfatase A (ARSA) protein, which is required for the breakdown of cellular components. 
Treatment Approach: HMI-202 is AAVHC mediated gene delivery and integration of the correct ARSA gene into the genome
Clinical Stage: IND Enabling Study

Therapeutic Platform: AAVHSC-mediated gene transfer and homology-directed precise integration of the transgene into the genome

Overview of Pipeline

Homology Therapeutics Stock

Updated on 03-Oct-2020

Comments

Popular posts from this blog

Carbohydrate Metabolism: MCQs and answers on Glycolysis & Gluconeogenesis

                                      MCQ on Glycolysis & Gluconeogenesis 1) Which of the following enzyme is not involved in galactose metabolism? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 2) Which of the following enzyme is defective in galactosemia (type I) - a fatal genetic disorder in infants? a) Glucokinase b) Galactokinase c) Galactose-1-Phosphate Uridyl transferase d) UDP-Galactose 4- epimerase 3) In the liver, the accumulation of which of the following metabolite attenuates the inhibitory of ATP on phosphofructokinase? a) Glucose-6-Phosphate b) Citrate c) Fructose-1,6-Bisphosphate d) Fructose-2,6-Bisphosphate 4) Mutation in which of the following enzymes leads to a glycogen storage disease known as "Tarui’s disease"? a) Glucokinase b) Phosphofructokinase c) Phosphoglucomutase d) Pyruvate Kinase 5) E...

MCQs and Answers on cultivation (culture/incubation), Isolation and Identification of microorganisms: Medical Microbiology

40 plus questions - Multiple Choice Questions on Classification, Culture, and Identification of the microorganisms 1. Which of the following microorganism has the cocci cell shapes and sizes arranged usually in tetrad structures? a)  Streptococcus pneumoniae b)  Staphylococcus aureus c)  Chlamydia trachomatis d)  Neisseria meningitidis 2. What are the different growth morphology and cell structures used for the classification of fungi? Select all the correct answers: a) Yeast b) Mold c) Mycelia d) Protozoa 3. Which of the following media is formulated with additional nutrients to support the growth of fastidious or nutritionally demanding bacteria that may not grow well on basic media? a) Differential media b) Enriched media c) Nutrient agar (media) d) Selective media 4. Which of the following metabolic characteristic is a distinguishing characteristic and identification of colonies of  E. coli ? a) Hydrogen sulfide formation b) Indole Formation c) Lactose fe...

Multiple Choice Questions (MCQs) on Diabetes Mellitus: Pathogenesis, Diagnosis and Treatment

                                        MCQs on Diabetes mellitus 1) Diabetes mellitus is a disorder characterized by hyperglycemia.  Which of the following is not the common characteristic features of type 2 diabetes mellitus ? a) Impaired insulin secretion b) Increased Insulin resistance  c) Diabetic ketoacidosis d) Excessive hepatic glucose production 2) Which of the following are the characteristic features of type 1 diabetes mellitus? a) Type 1 diabetes is caused by an absolute deficiency of insulin. b) Type 1 diabetes is associated with the autoimmune destruction of beta cells.  c) Patients with  uncontrolled type 1 diabetes present with diabetic ketoacidosis d) All of the above   3) Which of the following serum measurements are not used for the diagnosis of diabetes mellitus? a) Fasting blood glucose d) Postprandial blood glucose  c) Insulin ...